JPY 192.0
(1.05%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -661.75 Million JPY | -6.32% |
2022 | -594.05 Million JPY | -168.74% |
2021 | 740.33 Million JPY | -35.52% |
2020 | 1.16 Billion JPY | 2868.14% |
2019 | 18.82 Million JPY | -83.32% |
2018 | 234.45 Million JPY | 180.3% |
2017 | -342.32 Million JPY | 5.9% |
2016 | -465.34 Million JPY | 39.66% |
2015 | -1.42 Billion JPY | -480.85% |
2014 | 128.66 Million JPY | 123.06% |
2013 | 3.23 Billion JPY | -551.41% |
2012 | 1.62 Billion JPY | 484.82% |
2011 | -31.01 Million JPY | 87.51% |
2010 | -265.81 Million JPY | -134.58% |
2009 | 712.97 Million JPY | 94.35% |
2008 | 401.66 Million JPY | 1009.94% |
2007 | -73 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 FY | - JPY | -6.32% |
2023 Q3 | -158.9 Million JPY | 29.52% |
2023 Q2 | -225.45 Million JPY | -12.6% |
2023 Q1 | -200.22 Million JPY | 66.57% |
2023 Q4 | -227.59 Million JPY | -43.22% |
2022 Q1 | -248.78 Million JPY | -418.75% |
2022 FY | - JPY | -168.74% |
2022 Q4 | -598.91 Million JPY | -258.74% |
2022 Q3 | -166.94 Million JPY | -18.22% |
2022 Q2 | -141.21 Million JPY | 43.24% |
2021 FY | - JPY | -35.52% |
2021 Q1 | 129.8 Million JPY | -40.83% |
2021 Q3 | -15.93 Million JPY | -172.5% |
2021 Q2 | 21.98 Million JPY | -83.06% |
2021 Q4 | 78.04 Million JPY | 589.67% |
2020 Q1 | 202.1 Million JPY | 172.08% |
2020 FY | - JPY | 2868.14% |
2020 Q2 | 217.75 Million JPY | 7.74% |
2020 Q3 | 148.29 Million JPY | -31.9% |
2020 Q4 | 219.36 Million JPY | 47.92% |
2019 Q1 | -101.78 Million JPY | -159.27% |
2019 Q2 | -96.85 Million JPY | 4.85% |
2019 Q3 | 41.92 Million JPY | 143.29% |
2019 Q4 | 74.28 Million JPY | 77.17% |
2019 FY | - JPY | -83.32% |
2018 FY | - JPY | 180.3% |
2018 Q3 | -8.03 Million JPY | 23.23% |
2018 Q2 | -10.46 Million JPY | -143.91% |
2018 Q1 | -4.29 Million JPY | 91.86% |
2018 Q4 | 171.73 Million JPY | 2237.29% |
2017 Q1 | -125.72 Million JPY | -55.53% |
2017 Q4 | -52.69 Million JPY | 48.52% |
2017 Q3 | -102.35 Million JPY | -6.12% |
2017 Q2 | -96.44 Million JPY | 23.29% |
2017 FY | - JPY | 5.9% |
2016 Q1 | -171.98 Million JPY | 48.35% |
2016 FY | - JPY | 39.66% |
2016 Q3 | -162.56 Million JPY | -27653.05% |
2016 Q4 | -80.83 Million JPY | 50.27% |
2016 Q2 | 590 Thousand JPY | 100.34% |
2015 Q2 | -106.83 Million JPY | 38.65% |
2015 FY | - JPY | -480.85% |
2015 Q4 | -332.97 Million JPY | -73.0% |
2015 Q3 | -192.46 Million JPY | -80.16% |
2015 Q1 | -174.14 Million JPY | -21.63% |
2014 Q2 | -48.36 Million JPY | 68.28% |
2014 Q3 | 187.5 Million JPY | 487.7% |
2014 Q4 | -143.17 Million JPY | -176.36% |
2014 FY | - JPY | 123.06% |
2014 Q1 | -152.45 Million JPY | 62.48% |
2013 Q2 | -36.54 Million JPY | 57.25% |
2013 Q4 | -406.32 Million JPY | -44.63% |
2013 FY | - JPY | -551.41% |
2013 Q3 | -280.94 Million JPY | -668.85% |
2013 Q1 | -85.46 Million JPY | -223.64% |
2012 Q2 | 121.3 Million JPY | 160.79% |
2012 Q3 | -43.03 Million JPY | -135.47% |
2012 Q4 | 69.12 Million JPY | 260.64% |
2012 FY | - JPY | 484.82% |
2012 Q1 | -199.55 Million JPY | -715.7% |
2011 FY | - JPY | 87.51% |
2011 Q2 | -26.55 Million JPY | 41.15% |
2011 Q3 | -61.13 Million JPY | -130.2% |
2011 Q4 | -24.46 Million JPY | 59.98% |
2011 Q1 | -45.12 Million JPY | 69.24% |
2010 Q2 | -101.58 Million JPY | -498.62% |
2010 Q1 | 25.48 Million JPY | 130.77% |
2010 FY | - JPY | -134.58% |
2010 Q3 | -47.97 Million JPY | 52.77% |
2010 Q4 | -146.7 Million JPY | -205.78% |
2009 Q2 | 296.89 Million JPY | 71.16% |
2009 FY | - JPY | 94.35% |
2009 Q4 | -82.8 Million JPY | -121.07% |
2009 Q3 | 393.06 Million JPY | 32.39% |
2009 Q1 | 173.46 Million JPY | 91.65% |
2008 Q1 | 168.83 Million JPY | 0.0% |
2008 FY | - JPY | 1009.94% |
2008 Q4 | 90.51 Million JPY | -34.45% |
2008 Q3 | 138.08 Million JPY | 6503.78% |
2008 Q2 | 2.09 Million JPY | -98.76% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 8.98 Billion JPY | 107.368% |
DNA Chip Research Inc. | -217 Million JPY | -204.954% |
Cosmo Bio Company,Limited | 669 Million JPY | 198.916% |
H.U. Group Holdings, Inc. | 13.64 Billion JPY | 104.849% |
FALCO HOLDINGS Co., Ltd. | 3.13 Billion JPY | 121.129% |
BML, Inc. | 16.41 Billion JPY | 104.03% |
Human Metabolome Technologies, Inc. | 306.48 Million JPY | 315.917% |